Sairopa B.V., today announced it has achieved a milestone event in its exclusive clinical development and option agreement with Exelixis, Inc. involving ADU-1805, an innovative anti-SIRP? antibody ...

Immune aging is a degenerative change in the immune ... but also enhance the sensibility of PD-1 blockade-based immunotherapy. PD-1/PD-L1 immune checkpoint blockade therapy has become a major ...

Thirteen proteins linked to brain aging in humans are identified in ... can counteract resistance to anti-PD-1 and anti-PD-L1 therapies in solid tumors. "This is your brain on drugs," the old ...

Acquired resistance to PD-L1 inhibition can rewire the interferon-regulated secretory machinery in tumor cells, altering the ...

There is growing evidence that immune-positron emission tomography (immuno-PET) can provide a real-time quantitative readout ...

The PD-L1 IHC 28-8 PharmDx test is used to provide information on PD-L1 expression as a biomarker for patient response to therapies containing anti-PD-1 antibodies.

"We found that people born with a deficiency in PD-1 or PD-L1 have reduced diversity in their antibodies and fewer memory B cells, which made it harder to generate high-quality antibodies against ...

Researchers from Suzhou Siran Biotech Co. Ltd. presented the discovery and preclinical characterization of SA-1211, an N-acetylgalactosamine (GalNAc)-conjugated siRNA dimer targeting both hepatitis B ...

A+E Networks has settled its “Live PD” dispute with Amazon-owned Big Fish Entertainment and Reelz. As part of the settlement, A+E and Amazon have struck a new multi-year licensing deal on A+E ...

Recently, scientists at Stanford University began to wonder why identical lab mice, bred with the same DNA and brought up in identical conditions, wound up so different in their old age.